Pembrolizumab (cervical cancer): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 3 March 2023 Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 1.4MB) Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 2MB)